Screener
Crinetics Pharmaceuticals CRNX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Trade accounts receivable, net | 5,683 | 592 |
| Inventory | 3,064 | 2,022 |
| Prepaid expenses and other current assets | 22,361 | 17,839 |
| Total current assets | 1,322,414 | 1,048,342 |
| Property and equipment, net | 13,497 | 14,296 |
| Operating lease right-of-use assets | 39,790 | 40,492 |
| Restricted cash, net of current portion | 800 | 800 |
| Prepaid expenses and other assets, net of current portion | 24,822 | 22,327 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Crinetics Pharmaceuticals's total current assets?
- Crinetics Pharmaceuticals (CRNX) reported total current assets of $1.32B in Q1 2026.
- How has Crinetics Pharmaceuticals's total current assets changed year-over-year?
- Crinetics Pharmaceuticals's total current assets increased by 2.4% year-over-year, from $1.29B to $1.32B.
- What is the long-term trend for Crinetics Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's total current assets has grown at a 42.6% compound annual growth rate (CAGR), from $177.49M to $1.05B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Crinetics Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude